Myriant Technologies, a Quincy, MA-based developer of biochemicals, has raised $60 million in equity financing from Thailand’s PTT Chemical Public Company, according to a press release. This year Myriant plans to begin construction on plant in Port of Lake Province, LA, where it will produce bio-based succinic acid. Myriant CEO Stephen Gatto told me in July that his company was aiming to raise $60 million from new and existing investors. The firm’s previous backers include the Stamford, CT, hedge funds Plainfield Asset Management and Camulos Capital, Houston-based NGP Capital Resources, and Itera, a global holding company.
Author: Ryan McBride
Ryan is an award-winning business journalist who contributes to our life sciences and technology coverage. He was previously a staff writer for Mass High Tech, a Boston business and technology newspaper, where he and his colleagues won a national business journalism award from the Society of American Business Editors and Writers in 2008. In recent years, he has made regular TV appearances on New England Cable News.
Prior to MHT, Ryan covered the life sciences, technology, and energy sectors for Providence Business News. He graduated with honors from the University of Rhode Island in 2001 with a bachelor’s degree in communications. When he’s not chasing down news, Ryan enjoys mountain biking and skiing in his home state of Vermont.
View all posts by Ryan McBride
